357 related articles for article (PubMed ID: 33827969)
1. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1).
Harrison SR; Garrido-Cumbrera M; Navarro-Compán V; Correa-Fernández J; Webb D; Christen L; Marzo-Ortega H
Rheumatol Adv Pract; 2021; 5(3):rkab098. PubMed ID: 34988357
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media.
Reuter K; Deodhar A; Makri S; Zimmer M; Berenbaum F; Nikiphorou E
Rheumatology (Oxford); 2021 Oct; 60(SI):SI77-SI84. PubMed ID: 33629107
[TBL] [Abstract][Full Text] [Related]
4. Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic.
Adnine A; Nadiri K; Soussan I; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
Curr Rheumatol Rev; 2021; 17(3):303-311. PubMed ID: 33504309
[TBL] [Abstract][Full Text] [Related]
5. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
6. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
[TBL] [Abstract][Full Text] [Related]
7. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
[TBL] [Abstract][Full Text] [Related]
8. Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic.
de Boer GM; Houweling L; Hendriks RW; Vercoulen JH; Tramper-Stranders GA; Braunstahl GJ
Chron Respir Dis; 2021; 18():14799731211029658. PubMed ID: 34219501
[TBL] [Abstract][Full Text] [Related]
9. Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1).
Benavent D; Garrido-Cumbrera M; Plasencia-Rodríguez C; Marzo-Ortega H; Christen L; Correa-Fernández J; Plazuelo-Ramos P; Webb D; Navarro-Compán V
Ther Adv Musculoskelet Dis; 2022; 14():1759720X211066685. PubMed ID: 35069810
[TBL] [Abstract][Full Text] [Related]
10. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study.
Smith TO; Belderson P; Dainty JR; Birt L; Durrant K; Chipping JR; Tsigarides J; Yates M; Naughton F; Werry S; Notley C; Shepstone L; MacGregor AJ
BMJ Open; 2021 Jun; 11(6):e048772. PubMed ID: 34083347
[TBL] [Abstract][Full Text] [Related]
11. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study.
Sacre JW; Holmes-Truscott E; Salim A; Anstey KJ; Drummond GR; Huxley RR; Magliano DJ; van Wijngaarden P; Zimmet PZ; Speight J; Shaw JE
Diabet Med; 2021 Sep; 38(9):e14611. PubMed ID: 34053106
[TBL] [Abstract][Full Text] [Related]
12. Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases.
Palmer JL; Siddle HJ; Redmond AC; Alcacer-Pitarch B
J Foot Ankle Res; 2021 Jan; 14(1):4. PubMed ID: 33413562
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Risk Factors Associated With Self-reported Psychological Distress Among Children and Adolescents During the COVID-19 Pandemic in China.
Qin Z; Shi L; Xue Y; Lin H; Zhang J; Liang P; Lu Z; Wu M; Chen Y; Zheng X; Qian Y; Ouyang P; Zhang R; Yi X; Zhang C
JAMA Netw Open; 2021 Jan; 4(1):e2035487. PubMed ID: 33496797
[TBL] [Abstract][Full Text] [Related]
14. What Is the Impact of the COVID-19 Pandemic on Quality of Life and Other Patient-reported Outcomes? An Analysis of the Hand-Wrist Study Cohort.
Cohen A; Selles RW; De Ridder WA; Ter Stege MHP; Souer JS; Wouters RM;
Clin Orthop Relat Res; 2021 Feb; 479(2):335-345. PubMed ID: 33044314
[TBL] [Abstract][Full Text] [Related]
15. Mental Health Burden in Different Professions During the Final Stage of the COVID-19 Lockdown in China: Cross-sectional Survey Study.
Du J; Mayer G; Hummel S; Oetjen N; Gronewold N; Zafar A; Schultz JH
J Med Internet Res; 2020 Dec; 22(12):e24240. PubMed ID: 33197231
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
[TBL] [Abstract][Full Text] [Related]
17. Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
Johnstone G; Treharne GJ; Fletcher BD; Lamar RSM; White D; Harrison A; Stebbings S
Rheumatol Int; 2021 Oct; 41(10):1763-1772. PubMed ID: 34297180
[TBL] [Abstract][Full Text] [Related]
18. Positive Psychological Factors and Impairment in Rheumatic and Musculoskeletal Disease: Do Psychopathology and Sleep Quality Explain the Linkage?
Hirsch JK; Altier HR; Offenbächer M; Toussaint L; Kohls N; Sirois FM
Arthritis Care Res (Hoboken); 2021 Jan; 73(1):55-64. PubMed ID: 32937011
[TBL] [Abstract][Full Text] [Related]
19. Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
Andreica I; Jast R; Rezniczek GA; Kiefer D; Buehring B; Kiltz U; Baraliakos X; Braun J
Clin Exp Rheumatol; 2022 Nov; 40(11):2044-2051. PubMed ID: 35084321
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, Psychological Responses and Associated Correlates of Depression, Anxiety and Stress in a Global Population, During the Coronavirus Disease (COVID-19) Pandemic.
Shah SMA; Mohammad D; Qureshi MFH; Abbas MZ; Aleem S
Community Ment Health J; 2021 Jan; 57(1):101-110. PubMed ID: 33108569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
